GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia
Open Access
- 15 April 2011
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 25 (7), 1135-1146
- https://doi.org/10.1038/leu.2011.50
Abstract
Gamma secretase inhibitors (GSIs) comprise a growing class of compounds that interfere with the membrane-bound Notch signaling protein and its downstream intra-nuclear transcriptional targets. As GSI-I (Z-LLNle-CHO) is also a derivative of a widely used proteosome inhibitor MG-132, we hypothesized that this compound might be active in precursor-B acute lymphoblastic leukemia (ALL) cell lines and patient samples. We found that GSI-I treatment of precursor-B ALL blasts induced apoptotic cell death within 18–24 h. With confirmation using RNA and protein analyses, GSI-I blocked nuclear accumulation of cleaved Notch1 and Notch2, and inhibited Notch targets Hey2 and Myc. Microarray analyses of 207 children with high-risk precursor-B ALL demonstrate that Notch pathway expression is a common feature of these neoplasms. However, microarray studies also implicated additional transcriptional targets in GSI-I-dependent cell death, including genes in the unfolded protein response, nuclear factor-κB and p53 pathways. Z-LLNle-CHO blocks both γ-secretase and proteosome activity, inducing more robust cell death in precursor-B ALL cells than either proteosome-selective or γ-secretase-selective inhibitors alone. Using Z-LLNle-CHO in a nonobese diabetes/severe combined immunodeficiency (NOD/SCID) precursor-B ALL xenograft model, we found that GSI-I alone delayed or prevented engraftment of B-lymphoblasts in 50% of the animals comprising the experimental group, suggesting that this compound is worthy of additional testing.Keywords
This publication has 43 references indexed in Scilit:
- The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibitionBreast Cancer Research, 2009
- Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cellsBlood, 2009
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- NOTCH Is Part of the Transcriptional Network Regulating Cell Growth and Survival in Mouse PlasmacytomasCancer Research, 2008
- Off the beaten pathway: the complex cross talk between Notch and NF-κBLaboratory Investigation, 2008
- Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.2007
- Notch, a Universal Arbiter of Cell Fate DecisionsScience, 2006
- Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell linesBlood, 2004
- Kick it up a Notch: NOTCH1 activation in T-ALLCancer Cell, 2004
- Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein responseNature, 1999